期刊論文（110.01～110.12）

篇序

作者
姓名(順位)

論文題目

論文性質

期刊名稱/年份/卷期/頁次

屬性

所屬學門領域

所屬學門領域排名

Impact Factor

1

杜漢祥 (3)

Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region.

Original Article

Cardiovasc Diabetol. 2021 Oct 9;20(1):204.

SCI

Endocrinology & Metabolism

10/145

IF

9.951

2

余文良(4,C)

Letter

Clin Infect Dis 2021Vol 72/No 5/P 899-900

SCI

Infectious Disease

3/92

IF

9.079

3

杜漢祥 (4)

Original Article

Eur J Prev Cardiol. 2021 Apr 23;28(3):326-334.

SCI

Cardiac & cardiovascular System

18/141

IF 7.804

4

沈修年(2,C)

Thyroid Abscess Associated With Pyriform Sinus Fistula

Case Report

Mayo Clinic Proceedings

Vol 96/No 11/P 2854-2855

SCI

Medicine, General & Internal

14/315

IF 7.616

5

杜漢祥 (C)

Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region.

Original Article

Front Cardiovasc Med. 2021 Oct 29;8:750381.

SCI

Cardiac & cardiovascular System

30/141

IF

6.05

6

陳欽明(12)

Incidence And Management Of Metabolic Acidosis With Sodium Bicarbonate In The ICU: An International Observational Study

Research Article

Crit Care Vol /No /P25-45

SCI

Critical Care Medicine

6 / 36

IF 6.407

7

陳奇祥(5)

陳欽明(7)

余文良(8,C)

The Impacts Of Aspergillosis On Outcome, Burden And Risks For Mortality In Influenza Patients With Critical Illness

Original article

Journal Of Fungi 2021

Vol 7/No 922/P 1-14

SCI

Mycology

4/29

IF 5.816

8

余文良(2,C)

Klebsiella Pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution Over 20 Years, 1998–2019

Review Article

International Journal Of Antimicrobial Agents　2021Vol 58/No 01/P 106354

SCI

Infectious Diseases

17/92

IF 5.283

9

陳奇祥(6)

余文良(7,C)

Epidemiological Correlation Of Pulmonary Aspergillus Infections With Ambient Pollutions And Influenza A (H1N1) In Southern Taiwan

Original Article

J Of Fungi 2021　

Vol 7/No 3/P 227-

SCI

Mycology

4/29

IF 5.816

10

余文良(2,C)

Appropriate Use Of Antimicrobial Therapy For Covid-19 Co-Infection

Letter

Immunotherapy 2021 Sep;13(13):1067-1070.

SCI

Immunology

83/162

IF 4.196

11

余文良(2,C)

Covid-19 Associated With Pulmonary Aspergillosis: A Literature Review

Review Article

J Microbiol Immunol 2021　Vol 54/No 1/P 46-53

SCI

Infectious Diseases

28/92

IF

4.399

12

陳欽明(2)

陳奇祥(5)

余文良(6,C)

A Mysterious Surge Of Aspergillosis Among Non-Sars-Cov-2 Patients During Covid-19 Pandemic

Letter

J Microbiol Immunol 2021　Vol 54/No 1/P 156-158

SCI

Infectious Diseases

28/92

IF 4.399

13

杜漢祥 (6)

Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae.

Original Article

J Microbiol Immunol Infect. 2021 Jun;54(3):447-456.

SCI

Infectious Diseases

28/92

IF 4.399

14

余文良 (1)

杜漢祥 (2)

A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs

Review Article

Cardiovasc Drugs Ther. 2021 Apr;35(2):205-214

SCI

Cardiac & Cardiovascular

61/141

IF 3.727

15

杜漢祥 (3)

Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases.

Original Article

Cardiovasc Drugs Ther. 2021 Jun;35(3):539-547.

SCI

Cardiac & cardiovascular System

61/141

IF 3.727

16

陳志金(4)

Shortening The Time Of The Identification And Antimicrobial Susceptibility Testing On Positive Blood Cultures With MALDI-TOF MS

Original Article

Diagnostics (Basel)

SCI

Medicine, General & Internal

45/167

IF 3.706

17

余文良(2,C)

Cefoperazone/Sulbactam: New Composites Against Multiresistant Gram Negative Bacteria?

Review Article

Infect Genet Evol　

2021Vol 88/No /P 1-9

SCI

Infectious Diseases

51/92

IF 3.342

18

陳欽明(8)

Clinical Efficacy Of Cefoperazone-Sulbactam Versus Piperacillin-Tazobactam In The Treatment Of Hospital-Acquired Pneumonia And Ventilator-Associated Pneumonia

Original Article

Infect Drug Resist Vol 14/No /P 2251-2258

SCI

Infectious Diseases

42 / 93

IF 2.984

19

沈修年(9,C)

Simple Scoring Algorithm To Identify Community-Dwelling Older Adults With Limited Health Literacy: A Cross-Sectional Study In Taiwan

Research Article

BMJ Open

Vol 11/No 11/P E045411

SCI

Medicine, General & Internal

52 / 165

IF 2.692

20

余文良 (1)

杜漢祥 (2)

Cardiovascular Complications Of COVID-19 And Associated Concerns: A Review

Review Article

Acta Cardiol Sin. 2021 Jan;37(1):9-17. 

SCI

Cardiac & Cardiovascular

84/141

IF 2.672

21

陳志金(1)

The Impact Of COVID-19 Control Measures On The Utilization Of Emergency Department During Lunar New Year In Taiwan

Letter

Am J Emerg Med. 2021 May;43:252-254.

SCI

Emergency Medicine

13/32

IF

2.469

22

杜漢祥 (2)余文良(4, C)

Cardiac Involvement Of Covid-19: A Comprehensive Review

Review Article

Am J Med Sci. 2021 Jan;361(1):14-22. 

SCI

Medicine, General & Internal

84/169

IF 2.378

23

杜漢祥 (2)

A Rare Cause of Left Atrium Compression.

Case Report

Int Heart J. 2021 Jul 6.

SCI

Cardiac & cardiovascular System

117/141

IF

1.862

24

余文良(2,C)

Gastrointestinal Tract Bleeding Caused By Cytomegalovirus: A Comprehensive Review

國外教科書

Nova Book: Advances In Health And Disease Vol /No /P 1-44

25

余文良(4,C)

Molecular Epidemiology Of Klebsiella Pneumoniae Producing Kpc-17 And Ndm-1 Carbapenemases In Southern Taiwan

國外教科書

Advances In medicine And Biology vol /No /P 185-215

26

杜漢祥(1)

第五章、重症病人臨床表現與實驗室檢查

國內指引

新型冠狀病毒感染(COVID-19)重症照護暫行共識第二版

27

陳欽明(1)

新冠肺炎的重症危險因子及復健考量的分類建議

國內指引

新型冠狀病毒感染復健治療指引Vol /NO 3/P 6-9

28

陳欽明(1,C)

急性高碳酸呼吸衰竭

國內指引

濕化高流量氧氣重症治療台灣專家共識指引Vol /NO 3/P 26-29

29

陳欽明(1,C)

一般重症照護—第二版

國內指引

新型冠狀病毒感染(COVID-19)重症照護暫行共識第二版

30

陳欽明(1,C)

陳奇祥(2)

維生素D 狀態及其單次巨量補充對台灣成人重症患者的預後指標及死亡之影響：回溯性研究

Original Article

Resuscitation & Intensive Care Med Vol 12/No /P 121-136

31

黃惠美(1)

鄭鴻志(2)

陳奇祥(3)

陳欽明(4,C)

智慧化醫療改善呼吸器品質

Original Article

Resuscitation & Intensive Care Med Vol 6/No /P 53-62